Hikma Pharmaceuticals PLC | Cash Flow
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
190,647.50
219,852.70
208,141.90
155,636.30
573,060.50
219,738.30
Depreciation, Depletion & Amortization
46,702.20
40,691.00
46,471.90
83,006.00
105,604.60
81,745.60
Other Funds
5,118.10
1,214.70
9,818.00
2,223.40
2,329.50
3,749.80
Funds from Operations
206,641.40
227,140.60
238,250.50
249,018.00
275,659.20
305,233.70
Changes in Working Capital
13,434.90
10,324.60
28,799.50
70,406.90
24,848.20
18,749
Net Operating Cash Flow
193,206.50
237,465.20
209,451.00
178,611.10
300,507.30
286,484.70
Capital Expenditures
47,981.80
71,664.70
89,671.20
140,813.80
117,252.20
Sale of Fixed Assets & Businesses
639.80
607.30
20,290.60
741.10
5,435.50
Purchase/Sale of Investments
15,993.90
-
13,745.20
4,446.80
6,212.00
Net Investing Cash Flow
74,851.50
210,135.40
107,998.20
516,564.10
122,687.80
Cash Dividends Paid - Total
24,950.50
33,403.00
41,890.20
57,066.60
61,343.90
Issuance/Reduction of Debt, Net
91,485.20
75,916.00
109,961.80
113,392.10
60,567.40
Net Financing Cash Flow
122,833.30
41,298.30
78,544.10
54,102.10
124,240.80
Net Change in Cash
5,757.80
68,020.70
174,760.70
294,967.80
53,578.80
Free Cash Flow
155,460.90
182,198.40
155,779.20
88,193.90
217,421.30
Net Assets from Acquisitions
11,515.60
136,648.80
-
381,679.40
4,659.00
Other Sources
-
607.30
-
17,787.00
-
Change in Capital Stock
1,279.50
-
654.50
-
-
Exchange Rate Effect
1,279.50
607.30
5,236.30
11,116.90
-
Other Uses
-
3,036.60
24,872.30
8,152.40
-
About Hikma Pharmaceuticals
View Profile
